查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1739179

全球医用同位素市场

Medical Isotopes
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 266 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年全球医用同位素市场规模将达88亿美元

全球医用同位素市场规模预计在2024年为59亿美元，预计到2030年将达到88亿美元，2024年至2030年的复合年增长率为6.9%。稳定同位素是本报告分析的细分市场之一，预计其复合年增长率为5.5%，到分析期结束时将达到49亿美元。放射性同位素细分市场在分析期间内的复合年增长率预计为9.1%。

美国市场规模估计为 16 亿美元，中国市场预期复合年增长率为 10.6%

美国医用同位素市场规模预计在2024年达到16亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到18亿美元，在2024-2030年的分析期间内，复合年增长率为10.6%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个国家的复合年增长率分别为3.6%和6.7%。在欧洲，预计德国的复合年增长率为4.5%。

全球医用同位素市场—主要趋势与驱动因素摘要

为什么医用同位素对于诊断影像和标靶治疗至关重要？

医用同位素在现代医疗保健中至关重要，因为它们应用广泛，包括诊断成像、标靶放射治疗和疾病监测。这些同位素——具有特定半衰期的放射性原子——在核医学程序中用作示踪剂，用于观察器官功能、检测肿瘤、评估代谢活动和监测治疗结果。Technetium-99m (Tc-99m)、氟-18 (F-18)、碘-131 (I-131) 和镏-177 (Lu-177) 等主要同位素广泛应用于 SPECT、PET 和放射治疗方案。

随着癌症、心血管疾病和神经系统疾病的发生率不断上升，核医学影像的需求也日益增长，而医用同位素是精准诊断的核心。与传统的解剖结构成像不同，同位素扫描能够即时提供生理和生化讯息，从而实现更早的发现、更准确的疾病分期和个人化治疗方案。随着医疗保健产业将重点转向基于价值的护理和个人化医疗，医用同位素正逐渐成为数据丰富、微创诊断和治疗解决方案的关键推动因素。

生产技术和供应链模式如何发展以满足市场需求？

为满足日益增长的全球需求并解决长期存在的供应漏洞，医用同位素生产正在经历重大变革时期。传统上，同位素生产依赖于使用高浓缩铀 (HEU) 的老化核子反应炉，如今正转向使用低浓缩铀 (LEU) 靶和非核子反应炉替代方案，例如迴旋加速器、线性加速器和基于发电机的系统。这项转变的推动因素包括安全担忧以及减少武器级核子材料在民用应用中使用的监管压力。

基于迴旋加速器的生产，尤其是对于F-18等短寿命同位素的生产，因其能够最大限度地减少运输过程中的放射性崩坏并服务于局部医疗保健网络而日益受到青睐。基于发生器的解决方案，例如钼-99/Technetium-99m（Mo-99/Tc-99m）系统，可以实现现场同位素提取，从而减少对集中式供应链的依赖。各国政府和私人相关人员相关者正在投资支持同位素供应弹性的基础设施，包括备用反应器、区域迴旋加速器网路和放射性药物生产设施。随着这些发展，关键同位素的供应途径正变得更加稳定、多样化和可扩展。

哪些临床领域和手术量正在推动全球同位素的使用？

医用同位素需求最高的领域是肿瘤科、心臟科和神经科。在肿瘤科，同位素既用于诊断（例如，使用F-18 FDG进行PET显像以识别肿瘤和转移病灶），也用于治疗（例如，使用I-131显像治疗甲状腺癌，使用Lu-177显像治疗前列腺癌）。核子医学影像使肿瘤学家能够比形态学成像技术更早评估肿瘤代谢和治疗反应。同样，使用Tc-99m甲氧基异丁基异腈进行心臟压力测试有助于检测冠状动脉疾病和心肌灌注障碍，从而对心血管疾病的管理做出重大贡献。

神经系统应用日益受到关注，尤其是在阿兹海默症、帕金森氏症和癫痫的早期发现方面。使用F-18或碳基同位素的PET成像可用于绘製脑活动图谱，并在出现身体症状之前评估神经退化。在整形外科和内分泌科，同位素也有助于诊断骨转移和甲状腺功能障碍。随着人口老化和非传染性疾病在全球的流行，核子医学检查的数量正在增加，尤其是在门诊影像中心、癌症医院和学术研究机构。

什么将推动医用同位素市场的长期成长和创新？

医用同位素市场的成长得益于诊断影像量的增加、标靶放射性核种治疗的扩展、监管现代化以及放射性药物研发的进步。将诊断和治疗能力整合到单一同位素平台的治疗诊断学日益普及，正在创造巨大的商业性和临床机会。例如，镥-177和锕-225正在被开发用于转移性癌症的成像和治疗，从而实现更精准的治疗匹配和即时疗效追踪。

美国能源部/国家核安局倡议和欧盟「地平线」计划等全球官民合作关係正在资助下一代同位素生产技术和放射性药物研发管线。此外，加拿大、印度、韩国和南非等国家正在扩大国内同位素生产，以减少对有限的全球供应商的依赖。新兴市场核子医学领域的扩张以及PET-CT和PET-MRI混合成像系统的集成，正在增强对同位素的需求。

同时，跨市场监管协调和药典标准的更新正在简化新型放射性示踪剂和标记试剂套件的核准途径。随着精准医疗和分子诊断技术的不断发展，医用同位素的战略作用将进一步深化，使其成为全球高性能、个人化医疗基础设施的基石。

部分

类型（稳定同位素、放射性同位素）；最终用户（医院、诊断中心、研究机构）

受访公司范例（值得关注的32家公司）

  • ARTMS Inc.
  • Bayer AG
  • Bruce Power
  • BWXT Medical Ltd.
  • Cambridge Isotope Laboratories, Inc.
  • Cardinal Health, Inc.
  • Curium Pharma
  • Eckert & Ziegler
  • GE Healthcare
  • International Isotopes Inc.
  • ITM Isotope Technologies Munich SE
  • Jubilant Radiopharma
  • Lantheus Holdings, Inc.
  • NorthStar Medical Radioisotopes, LLC
  • NTP Radioisotopes SOC Ltd
  • Nusano, Inc.
  • Orano Med
  • SHINE Technologies
  • Sotera Health（Nordion）
  • Theragnostics Ltd

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口（成品和原始OEM）来预测其竞争地位的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、盈利下降、供应链重组以及其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家（14,949位）、智库（62家）以及贸易和产业协会（171家）的专家的意见，以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计，这场动盪将在未来2-3个月内逐渐平息，新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月：谈判阶段

在4月的报告中，我们将探讨关税对全球整体市场的影响，并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将在 7 月收到免费更新，最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪了 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家，他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP34059

Global Medical Isotopes Market to Reach US$8.8 Billion by 2030

The global market for Medical Isotopes estimated at US$5.9 Billion in the year 2024, is expected to reach US$8.8 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Stable Isotopes, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$4.9 Billion by the end of the analysis period. Growth in the Radioisotopes segment is estimated at 9.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 10.6% CAGR

The Medical Isotopes market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 10.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Medical Isotopes Market - Key Trends & Drivers Summarized

Why Are Medical Isotopes Central to Diagnostic Imaging and Targeted Therapeutics?

Medical isotopes have become indispensable to modern healthcare due to their wide-ranging applications in diagnostic imaging, targeted radiotherapy, and disease monitoring. These isotopes-radioactive atoms with specific half-lives-are used as tracers in nuclear medicine procedures to visualize organ function, detect tumors, assess metabolic activity, and monitor treatment efficacy. Key isotopes such as Technetium-99m (Tc-99m), Fluorine-18 (F-18), Iodine-131 (I-131), and Lutetium-177 (Lu-177) are widely deployed in SPECT, PET, and radiotherapeutic protocols.

With the growing incidence of cancer, cardiovascular disease, and neurological disorders, demand for nuclear imaging is increasing steadily, placing medical isotopes at the heart of precision diagnostics. Unlike traditional imaging, which reveals anatomical structure, isotopic scans provide physiological and biochemical information in real time-enabling early detection, more accurate staging, and personalized treatment plans. As the healthcare industry pivots toward value-based care and personalized medicine, medical isotopes are emerging as crucial enablers of data-rich, low-invasiveness diagnostic and therapeutic solutions.

How Are Production Technologies and Supply Chain Models Evolving to Meet Market Demand?

Medical isotope production is undergoing significant transformation to meet rising global demand and address longstanding supply vulnerabilities. Traditionally reliant on aging nuclear reactors using highly enriched uranium (HEU), isotope production is now shifting toward low enriched uranium (LEU) targets and non-reactor alternatives such as cyclotrons, linear accelerators, and generator-based systems. This transition is driven by both security concerns and regulatory pressure to reduce the use of weapons-grade nuclear materials in civilian applications.

Cyclotron-based production, particularly for short-lived isotopes like F-18, is gaining traction due to its ability to serve localized healthcare networks with minimal radioactive decay during transit. Generator-based solutions-such as molybdenum-99/technetium-99m (Mo-99/Tc-99m) systems-enable on-site isotope extraction, reducing dependency on centralized supply chains. Governments and private-sector stakeholders are investing in infrastructure to support isotope supply resilience, including backup reactors, regional cyclotron networks, and radiopharmaceutical manufacturing facilities. These developments are ensuring more stable, diversified, and scalable supply pathways for critical medical isotopes.

Which Clinical Fields and Procedural Volumes Are Driving Isotope Utilization Globally?

The highest demand for medical isotopes originates from oncology, cardiology, and neurology segments. In oncology, isotopes are used in both diagnostics (e.g., PET imaging with F-18 FDG to identify tumors and metastases) and therapeutics (e.g., I-131 for thyroid cancer or Lu-177 for prostate cancer). Nuclear imaging enables oncologists to assess tumor metabolism and treatment response earlier than morphological imaging techniques. Similarly, cardiac stress tests using Tc-99m sestamibi help detect coronary artery disease and myocardial perfusion deficits, contributing significantly to cardiovascular disease management.

Neurological applications are gaining prominence, especially for early detection of Alzheimer’s disease, Parkinson’s disease, and epilepsy. PET imaging with F-18 or carbon-based isotopes is used to map brain activity and evaluate neurodegeneration before physical symptoms manifest. In orthopedics and endocrinology, isotopes also help diagnose bone metastases and thyroid dysfunction. As population aging intensifies and non-communicable diseases become more prevalent globally, procedural volumes for nuclear medicine are rising-particularly in outpatient imaging centers, specialty cancer hospitals, and academic research institutions.

What Is Driving Long-Term Growth and Innovation in the Medical Isotopes Market?

The growth in the medical isotopes market is driven by rising diagnostic imaging volumes, expansion of targeted radionuclide therapy, regulatory modernization, and advancements in radiopharmaceutical R&D. The increasing adoption of theranostics-combining diagnostic and therapeutic capabilities into a single isotope platform-is creating significant commercial and clinical opportunities. For instance, Lu-177 and Actinium-225 are being developed to both image and treat metastatic cancer, allowing for better treatment matching and real-time response tracking.

Global public-private partnerships, such as the U.S. DOE/NNSA initiatives and EU Horizon projects, are funding next-generation isotope production technologies and radiopharmaceutical pipelines. Additionally, countries like Canada, India, South Korea, and South Africa are scaling up domestic isotope production to reduce dependence on limited global suppliers. The expansion of nuclear medicine departments in emerging markets and the integration of PET-CT and PET-MRI hybrid imaging systems are reinforcing demand.

Meanwhile, regulatory harmonization across markets and updated pharmacopoeia standards are streamlining approval pathways for novel radiotracers and labeling kits. As precision medicine and molecular diagnostics continue to advance, the strategic role of medical isotopes will deepen-positioning them as a cornerstone of high-performance, personalized healthcare infrastructure globally.

SCOPE OF STUDY:

The report analyzes the Medical Isotopes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Stable Isotopes, Radioisotopes); End-User (Hospitals, Diagnostic Centers, Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • ARTMS Inc.
  • Bayer AG
  • Bruce Power
  • BWXT Medical Ltd.
  • Cambridge Isotope Laboratories, Inc.
  • Cardinal Health, Inc.
  • Curium Pharma
  • Eckert & Ziegler
  • GE Healthcare
  • International Isotopes Inc.
  • ITM Isotope Technologies Munich SE
  • Jubilant Radiopharma
  • Lantheus Holdings, Inc.
  • NorthStar Medical Radioisotopes, LLC
  • NTP Radioisotopes SOC Ltd
  • Nusano, Inc.
  • Orano Med
  • SHINE Technologies
  • Sotera Health (Nordion)
  • Theragnostics Ltd

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Medical Isotopes - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Nuclear Imaging in Oncology Propels Growth in Medical Isotope Applications
    • Expansion of PET and SPECT Imaging Throws the Spotlight on Short-Lived Radioisotope Production
    • Increased Use of Technetium-99m in Diagnostic Procedures Strengthens Global Market Demand
    • Growth in Targeted Alpha Therapy Accelerates Innovation in Therapeutic Isotope Development
    • Surge in Thyroid and Bone Cancer Cases Drives Use of Iodine-131 and Samarium-153
    • Focus on Cyclotron and Non-Reactor-Based Isotope Production Enhances Supply Chain Resilience
    • Government Support for Domestic Isotope Production Facilities Spurs Regional Capacity Expansion
    • Technological Advancements in Radiopharmaceutical Synthesis Boost Clinical Efficiency
    • Growing Need for Companion Diagnostics Fuels Demand for Theranostic Isotope Pairing
    • Increasing Use of Lutetium-177 in Prostate Cancer Treatment Expands Targeted Radiotherapy Applications
    • Shortage of Reactor-Based Supply Chains Throws the Spotlight on Decentralized Production Models
    • Rising Investment in Cold Kits and Generator-Based Distribution Strengthens Delivery Infrastructure
    • Regulatory Streamlining for Isotope Approvals Accelerates Time-to-Market for Novel Radiotracers
    • Integration of Isotopes in Personalized Medicine Supports Patient-Specific Diagnostic Pathways
    • Emergence of Actinium-225 and Other Alpha Emitters Creates Opportunities in Rare Cancer Treatment
    • Improved Logistics and Half-Life Optimization Techniques Drive Efficiency in Regional Supply Chains
    • Collaboration Between Research Institutions and Pharma Companies Expands Clinical Research Pipeline
    • Use of AI in Radiopharmaceutical Planning Enhances Patient Scheduling and Isotope Utilization
    • Expansion of Radiopharmacy Networks in Emerging Markets Supports Accessibility of Diagnostic Isotopes
    • Global Aging Population and Increased Cancer Screening Rates Sustain Long-Term Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Medical Isotopes Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Medical Isotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Stable Isotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Stable Isotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Stable Isotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Radioisotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • JAPAN
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • CHINA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • EUROPE
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Medical Isotopes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • FRANCE
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • GERMANY
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Medical Isotopes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • INDIA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Medical Isotopes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Medical Isotopes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • AFRICA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030

IV. COMPETITION